Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D9CI7V
|
|||
| Drug Name |
Donaperminogene seltoplasmid
|
|||
| Synonyms |
VM202
Click to Show/Hide
|
|||
| Drug Type |
Gene therapy
|
|||
| Indication | Diabetic foot ulcer [ICD-11: BD54; ICD-9: 707] | Phase 3 | [1] | |
| Diabetic neuropathy [ICD-11: 8C0Z] | Phase 3 | [2] | ||
| Amyotrophic lateral sclerosis [ICD-11: 8B60.0; ICD-9: 335.2] | Phase 1/2 | [3] | ||
| Company |
ViroMed
|
|||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | ClinicalTrials.gov (NCT02563522) Safety and Efficacy Study of VM202 in the Treatment of Chronic Non-Healing Foot Ulcers. U.S. National Institutes of Health. | |||
| REF 2 | ClinicalTrials.gov (NCT02427464) Phase 3 Gene Therapy for Painful Diabetic Neuropathy. U.S. National Institutes of Health. | |||
| REF 3 | ClinicalTrials.gov (NCT02039401) Safety Study of VM202 to Treat Amyotrophic Lateral Sclerosis. U.S. National Institutes of Health. | |||
| REF 4 | Clinical pipeline report, company report or official report of ViroMed. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.